Interferon-beta gene therapy for cancer: basic research to clinical application.

Area of Science:

• Oncology
• Gene Therapy
• Molecular Biology

Background:

• Conventional interferon-beta protein therapy has limitations in treating certain cancers.
• Gene therapy offers a novel approach to enhance therapeutic efficacy.

Purpose of the Study:

• To describe the development of interferon-beta gene therapy from basic research to clinical application in Japan.
• To evaluate the biological and biochemical characteristics and clinical effectiveness of this novel gene therapy.

Main Methods:

• Development of cationic liposomes for interferon-beta gene transfer into tumor cells.
• Preclinical studies to confirm safety and efficacy.
• Pilot clinical trial in patients with malignant glioma.

Main Results:

• Interferon-beta gene transfer induced apoptosis in interferon-beta protein-resistant tumor cells (glioma, melanoma, renal cell carcinoma).
• Apoptosis induction correlated with intracellular interferon-beta mRNA levels, prolonged signal transduction pathway activation, and DNase gamma activation.
• The developed lyophilized cationic liposomes containing interferon-beta gene were safe for clinical use.
• Pilot clinical trial demonstrated safety and effectiveness in malignant glioma patients.

Conclusions:

• Interferon-beta gene therapy is a safe and effective treatment for malignant glioma.
• This gene therapy approach differs from conventional protein therapy and can overcome resistance.
• Further applications in molecular targeting, cell therapy, and combination therapies are anticipated.